Gyre Therapeutics, Inc. Basic Shares Outstanding (Weighted Average)
Gyre Therapeutics, Inc. (GYRE) reported Basic Shares Outstanding (Weighted Average) of 100.64 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 100.64M shares, a 12.92% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 91.32M shares, a 5.67% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 91.26M shares, a 6.16% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 90.85M shares, a 6.08% increase year-over-year.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 89.34M shares, a 4.99% increase from fiscal 2024.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 85.09M shares, a 29.26% increase from fiscal 2023.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 65.83M shares, a 3.53% increase from fiscal 2022.
- Gyre Therapeutics, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 63.59M shares, a 107.53% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 100.64M shares 10-Q · filed 2026-08-07 | 96.00M shares 10-Q · filed 2026-08-07 | 94.40M shares derived: average of 3 quarters · filed 2026-08-07 | 93.52M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | 91.32M shares 10-Q · filed 2026-05-08 | 91.29M shares derived: average of 2 quarters · filed 2026-05-08 | 91.14M shares derived: average of 3 quarters · filed 2026-05-08 | 90.64M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | 91.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 91.05M shares derived: average of 2 quarters · filed 2026-03-13 | 90.41M shares derived: average of 3 quarters · filed 2026-08-07 | 89.34M shares 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | 90.85M shares 10-Q · filed 2025-11-07 | 89.98M shares derived: average of 2 quarters · filed 2026-08-07 | 88.71M shares 10-Q · filed 2025-11-07 | 88.09M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | 89.12M shares 10-Q · filed 2026-08-07 | 87.30M shares 10-Q · filed 2026-08-07 | 87.17M shares derived: average of 3 quarters · filed 2026-08-07 | 86.79M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | 86.42M shares 10-Q · filed 2026-05-08 | 86.19M shares derived: average of 2 quarters · filed 2026-05-08 | 86.01M shares derived: average of 3 quarters · filed 2026-05-08 | 85.88M shares derived: average of 4 quarters · filed 2026-05-08 | ||||
| 2024-12-31 | 85.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 85.80M shares derived: average of 2 quarters · filed 2026-03-13 | 85.70M shares derived: average of 3 quarters · filed 2026-03-13 | 85.09M shares 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | 85.64M shares 10-Q · filed 2025-11-07 | 85.57M shares derived: average of 2 quarters · filed 2025-11-07 | 84.81M shares 10-Q · filed 2025-11-07 | 81.74M shares derived: average of 4 quarters · filed 2025-11-07 | ||||
| 2024-06-30 | 85.50M shares 10-Q · filed 2025-08-11 | 84.38M shares 10-Q · filed 2025-08-11 | 80.44M shares derived: average of 3 quarters · filed 2025-08-11 | 76.23M shares derived: average of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | 83.27M shares 10-Q · filed 2025-05-09 | 77.91M shares derived: average of 2 quarters · filed 2025-05-09 | 73.14M shares derived: average of 3 quarters · filed 2025-05-09 | 70.75M shares derived: average of 4 quarters · filed 2025-05-09 | ||||
| 2023-12-31 | 72.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 68.08M shares derived: average of 2 quarters · filed 2025-03-17 | 66.58M shares derived: average of 3 quarters · filed 2025-03-17 | 65.83M shares 10-K · filed 2025-03-17 | ||||
| 2023-09-30 | 63.59M shares 10-Q · filed 2024-11-13 | 37.98M shares 10-Q · filed 2023-10-26 | 63.59M shares derived: average of 2 quarters · filed 2024-11-13 | 63.59M shares 10-Q · filed 2024-11-13 | 37.85M shares 10-Q · filed 2023-10-26 | 87.67M shares derived: average of 4 quarters · filed 2024-11-13 | ||
| 2023-06-30 | 63.59M shares 10-Q · filed 2024-08-13 | 37.80M shares 10-Q · filed 2023-08-14 | 63.59M shares 10-Q · filed 2024-08-13 | 37.78M shares 10-Q · filed 2023-08-14 | 95.70M shares derived: average of 3 quarters · filed 2024-08-13 | 79.65M shares derived: average of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | 63.59M shares 10-Q · filed 2024-05-13 | 37.76M shares 10-Q · filed 2023-05-15 | 111.76M shares derived: average of 2 quarters · filed 2024-05-13 | 85.00M shares derived: average of 3 quarters · filed 2024-05-13 | 71.62M shares derived: average of 4 quarters · filed 2024-05-13 | |||
| 2022-12-31 | 159.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | 95.71M shares derived: average of 2 quarters · filed 2024-03-27 | 74.30M shares derived: average of 3 quarters · filed 2024-03-27 | 63.59M shares 10-K · filed 2024-03-27 | 31.55M shares 10-K · filed 2023-03-30 | |||
| 2022-09-30 | 31.48M shares 10-Q · filed 2023-10-26 | 31.48M shares derived: average of 2 quarters · filed 2023-10-26 | 31.47M shares 10-Q · filed 2023-10-26 | 31.46M shares derived: average of 4 quarters · filed 2023-10-26 | ||||
| 2022-06-30 | 31.48M shares 10-Q · filed 2023-08-14 | 31.47M shares 10-Q · filed 2023-08-14 | 31.45M shares derived: average of 3 quarters · filed 2023-08-14 | 31.43M shares derived: average of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | 31.46M shares 10-Q · filed 2023-05-15 | 31.44M shares derived: average of 2 quarters · filed 2023-05-15 | 31.42M shares derived: average of 3 quarters · filed 2023-05-15 | 31.40M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 31.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 31.40M shares derived: average of 2 quarters · filed 2023-03-30 | 31.38M shares derived: average of 3 quarters · filed 2023-03-30 | 30.64M shares 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 31.38M shares 10-Q · filed 2022-11-14 | 31.36M shares derived: average of 2 quarters · filed 2022-11-14 | 30.38M shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 31.35M shares 10-Q · filed 2022-08-15 | 29.88M shares 10-Q · filed 2022-08-15 | ||||||
| 2013-09-30 | 33.64M shares 10-Q · filed 2013-11-06 | 33.64M shares derived: average of 2 quarters · filed 2013-11-06 | 33.63M shares 10-Q · filed 2013-11-06 | 33.62M shares derived: average of 4 quarters · filed 2014-03-14 | ||||
| 2013-06-30 | 33.63M shares 10-Q · filed 2013-08-07 | 33.62M shares 10-Q · filed 2013-08-07 | 33.62M shares derived: average of 3 quarters · filed 2014-03-14 | 33.59M shares derived: average of 4 quarters · filed 2014-03-14 | ||||
| 2013-03-31 | 33.62M shares 10-Q · filed 2013-05-08 | 33.61M shares derived: average of 2 quarters · filed 2014-03-14 | 33.57M shares derived: average of 3 quarters · filed 2014-03-14 | 33.53M shares derived: average of 4 quarters · filed 2014-03-14 | ||||
| 2012-12-31 | 33.61M shares 10-K · filed 2014-03-14 | 33.55M shares derived: average of 2 quarters · filed 2014-03-14 | 33.50M shares derived: average of 3 quarters · filed 2014-03-14 | 33.48M shares 10-K · filed 2013-03-15 | ||||
| 2012-09-30 | 33.49M shares 10-K · filed 2014-03-14 | 33.45M shares derived: average of 2 quarters · filed 2014-03-14 | 33.43M shares 10-Q · filed 2013-11-06 | 33.42M shares derived: average of 4 quarters · filed 2014-03-14 | ||||
| 2012-06-30 | 33.41M shares 10-K · filed 2014-03-14 | 33.40M shares 10-Q · filed 2013-08-07 | 33.39M shares derived: average of 3 quarters · filed 2014-03-14 | 33.39M shares derived: average of 4 quarters · filed 2014-03-14 | ||||
| 2012-03-31 | 33.39M shares 10-K · filed 2014-03-14 | 33.39M shares derived: average of 2 quarters · filed 2014-03-14 | 33.38M shares derived: average of 3 quarters · filed 2014-03-14 | 32.72M shares derived: average of 4 quarters · filed 2014-03-14 | ||||
| 2011-12-31 | 33.38M shares 10-K · filed 2013-03-15 | 33.38M shares derived: average of 2 quarters · filed 2013-03-15 | 32.50M shares derived: average of 3 quarters · filed 2013-03-15 | 31.64M shares 10-K · filed 2013-03-15 | ||||
| 2011-09-30 | 33.38M shares 10-K · filed 2013-03-15 | 32.05M shares derived: average of 2 quarters · filed 2013-03-15 | 31.05M shares 10-Q · filed 2012-11-08 | 30.46M shares derived: average of 4 quarters · filed 2013-03-15 | ||||
| 2011-06-30 | 30.73M shares 10-K · filed 2013-03-15 | 29.87M shares 10-Q · filed 2012-08-09 | 29.48M shares derived: average of 3 quarters · filed 2013-03-15 | 29.27M shares derived: average of 4 quarters · filed 2013-03-15 | ||||
| 2011-03-31 | 29.00M shares 10-K · filed 2013-03-15 | 28.86M shares derived: average of 2 quarters · filed 2013-03-15 | 28.78M shares derived: average of 3 quarters · filed 2013-03-15 | 28.71M shares derived: average of 4 quarters · filed 2013-03-15 | ||||
| 2010-12-31 | 28.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | 28.67M shares derived: average of 2 quarters · filed 2013-03-15 | 28.62M shares derived: average of 3 quarters · filed 2013-03-15 | 28.54M shares 10-K · filed 2013-03-15 | ||||
| 2010-09-30 | 28.62M shares 10-Q · filed 2011-11-03 | 28.57M shares derived: average of 2 quarters · filed 2011-11-03 | 28.48M shares 10-Q · filed 2011-11-03 | |||||
| 2010-06-30 | 28.51M shares 10-Q · filed 2011-08-09 | 28.41M shares 10-Q · filed 2011-08-09 | ||||||
| 2009-12-31 | 25.64M shares 10-K · filed 2012-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |